Charlie Javice’s fraud trial is revealing embarrassing details about the banking giant’s failed deal process.

The bank is changing “equity” to “opportunity” and renaming it Diversity, Opportunity and Inclusion, a memo sent out on Friday said.

JPM will replace "equity" with "opportunity" in rebranding its DEI programs. An exec says "e" meant "equal opportunity to us, ...

JPMorgan Chase Chief Operating Officer Jenn Piepszak said the bank was making some changes to its Diversity, Equity and ...

Sequoia Financial Advisors LLC lowered its position in Kingsway Financial Services Inc. (NYSE:KFS – Free Report) (TSE:KFS) by ...

We recently compiled a list of the 15 Best Biotech Stocks to Buy According to Billionaires. In this article, we are going to take a look at where BioMarin Pharmaceutical Inc.

In the same investor note, JP Morgan slashed its price target for Tesla shares to a mere $120, representing more than a 50% ...

In a report released on March 14, Jessica Fye from J.P. Morgan maintained a Buy rating on BioMarin Pharmaceutical (BMRN – Research Report), ...

What should I know about this firm? J.P. Morgan Securities LLC advisors not only assist individuals with building their money by providing a variety of wealth management services, but also help ...

Dynamic Biopsy non-invasively analyses dynamic biological processes within a specific organ or tissue to assess its health ...

In this episode of Denatured, BioSpace's Head of Insights Lori Ellis and Miruna Sasu, CEO of COTA, discuss the challenges of ...

Tevogen Bio (NASDAQ:TVGN – Get Free Report)‘s stock had its “buy” rating reaffirmed by stock analysts at D. Boral Capital in a research report issued on Tuesday,Benzinga reports. They presently have a ...